These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22805424)

  • 1. Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design.
    Shakhnovich V; Ward RM; Kearns GL
    Clin Pharmacol Ther; 2012 Sep; 92(3):388-92. PubMed ID: 22805424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Study of Off-label Proton Pump Inhibitor Use Among New Zealand Infants in the First Year of Life (2005-2012).
    Blank ML; Parkin L
    J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):179-184. PubMed ID: 28403034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?].
    Mouterde O; Bellaïche M; Dumant C; Mallet E
    Arch Pediatr; 2010 Jun; 17(6):739-40. PubMed ID: 20654868
    [No Abstract]   [Full Text] [Related]  

  • 4. Proton pump inhibitor use in infants: FDA reviewer experience.
    Chen IL; Gao WY; Johnson AP; Niak A; Troiani J; Korvick J; Snow N; Estes K; Taylor A; Griebel D
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):8-14. PubMed ID: 21946832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflux and Chronic Rhinosinusitis.
    Bock JM; Poetker DM
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):633-4. PubMed ID: 27280868
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
    J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1 year.
    Springer M; Atkinson S; North J; Raanan M
    Paediatr Drugs; 2008; 10(4):255-63. PubMed ID: 18590344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk awareness for proton pump inhibition: Necessitates review of recommendations in anti-reflux disease.
    Falk GL
    Surgeon; 2020 Jun; 18(3):189-190. PubMed ID: 31610985
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reasons for proton-pump-inhibitor failure in the treatment of gastroesophageal reflux disease].
    Juhász M; Tulassay Z
    Orv Hetil; 2008 Oct; 149(40):1881-8. PubMed ID: 18815107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux guidelines: the European experience.
    McCracken M
    J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):395-6. PubMed ID: 24795980
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular Risk of Proton Pump Inhibitors.
    Ariel H; Cooke JP
    Methodist Debakey Cardiovasc J; 2019; 15(3):214-219. PubMed ID: 31687101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan.
    Kawarazaki H; Nakashima A; Furusho M; Shimizu S; Nakata T
    Clin Exp Nephrol; 2020 Jun; 24(6):565-572. PubMed ID: 32147803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Refractory gastroesophageal reflux disease (GERD) and PPI safety].
    Huerta-Iga FM
    Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():1-3. PubMed ID: 24041041
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment and Management of Gastroesophageal Reflux in The Newborn.
    Chabra S; Peeples ES
    Pediatr Ann; 2020 Feb; 49(2):e77-e81. PubMed ID: 32045486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors for irritable infants.
    Smith CH; Israel DM; Schreiber R; Goldman RD
    Can Fam Physician; 2013 Feb; 59(2):153-6. PubMed ID: 23418240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for proton pump inhibitor prescriptions in paediatric intensive care unit.
    Joret-Descout P; Dauger S; Bellaiche M; Bourdon O; Prot-Labarthe S
    Int J Clin Pharm; 2017 Feb; 39(1):181-186. PubMed ID: 28093644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infants and proton pump inhibitors: tribulations, no trials.
    Orenstein SR; Hassall E
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):395-8. PubMed ID: 18030202
    [No Abstract]   [Full Text] [Related]  

  • 20. We Are Using Too Many PPIs, and We Need to Stop: A European Perspective.
    Lanas A
    Am J Gastroenterol; 2016 Aug; 111(8):1085-6. PubMed ID: 27166129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.